Supplementary Figure from Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure from Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma
Authors: Philip A. Philip, Ibrahim Azar, Joanne Xiu, Michael J. Hall, Andrew Eugene Hendifar, Emil Lou, Jimmy J. Hwang, Jun Gong, Rebecca Feldman, Michelle Ellis, Phil Stafford, David Spetzler, Moh'd M. Khushman, Davendra Sohal, A. Craig Lockhart, Benjamin A. Weinberg, Wafik S. El-Deiry, John Marshall, Anthony F. Shields, W. Michael Korn
Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, Caris Life Sciences (United States), Fox Chase Cancer Center, Cedars-Sinai Medical Center, University of Minnesota, Masonic Cancer Center, Levine Cancer Institute, USA Mitchell Cancer Institute, University of South Alabama, University of Cincinnati, Medical University of South Carolina, Georgetown University, Brown University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Funders: American Association for Cancer Research, Pancreatic Cancer Action Network, Amgen, Bristol-Myers Squibb, Minnesota Ovarian Cancer Alliance, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Celgene, FibroGen, University of Minnesota, Boston Scientific Corporation, Exelixis, Novocure, Incyte, Natera, Eisai, Ipsen, Sirtex Medical, Genentech, EMD Serono, National Cancer Institute, Daiichi Sankyo Europe
OpenAlex ID: W4361962826